About TissueVision
TissueVision is a company based in Somerville (United States) founded in 2005. TissueVision offers products and services including TissueCyte, SlicePlacer, and Custom Assays. TissueVision operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter Somerville, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tissuevision India Private Limited
- Date of Incorporation 13 Mar, 2023
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$2.49 M (USD), Grant
Aug 15, 2023
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TissueVision
TissueVision offers a comprehensive portfolio of products and services, including TissueCyte, SlicePlacer, and Custom Assays.
Delivers high-resolution 3D imaging for whole organ studies
Automates tissue section processing for research applications
Develops tailored assays for specific tissue analysis needs
People of TissueVision
Unlock access to complete
Unlock access to complete
Funding Insights of TissueVision
Investors in TissueVision
TissueVision has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and NIH SBIR/STTR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for TissueVision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TissueVision
Investment portfolio details for TissueVision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TissueVision
Detailed financials for TissueVision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tissuevision Comparisons
Peer comparison for TissueVision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TissueVision
TissueVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
Detailed competitors of TissueVision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tissuevision
Complete news archive for TissueVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TissueVision
TissueVision was founded in 2005 and raised its 1st funding round 3 years after it was founded.
TissueVision is headquartered in Somerville, United States. It is registered at Somerville, Massachusetts, United States.
Founded in 2005 and based in Somerville, United States, TissueVision operates as a contract research organization in the biomedical sector. Preclinical animal models are imaged and analyzed at the whole organ and tissue level using patented technology for automated, high-throughput fluorescence imaging. Multispectral biochemical signatures are captured sub-micron resolution. Turn-key packages convert raw samples into comprehensive reports, enabling evaluation of disease models and treatment profiles with clinically relevant biomarkers.
TissueVision's top competitors include Biocare Medical, Merck and Siemens Healthineers.
TissueVision offers TissueCyte, SlicePlacer, and Custom Assays.
TissueVision has 2 investors. Key investors include HHS, and NIH SBIR/STTR.